4//SEC Filing
Bent Bruce 4
Accession 0000899243-23-009452
CIK 0001468492other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 7:55 PM ET
Size
6.2 KB
Accession
0000899243-23-009452
Insider Transaction Report
Form 4
Bent Bruce
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2023-03-20+50,000→ 50,000 totalExercise: $0.97Exp: 2033-03-20→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]These options were granted to the Reporting Person effective as of March 20, 2023 (the "Effective Date"), pursuant to the approval of the Issuer's board of directors (the "Board") on March 20, 2023.
- [F2]The options shall vest in four equal increments, with the first tranche of the options vesting on June 20, 2023 (the "Initial Vesting Date"), with an additional one-fourth of the options vesting on each successive three-month anniversary of the Initial Vesting Date, subject to the Reporting Person's continued service on the Board through each applicable vesting date and subject to the terms of the Issuer's 2023 Equity Incentive Plan (the "2023 Plan").
- [F3]These options expire ten years from the Effective Date, unless terminated sooner in accordance with the 2023 Plan or the underlying options grant agreement.
Documents
Issuer
Heart Test Laboratories, Inc.
CIK 0001468492
Entity typeother
Related Parties
1- filerCIK 0001746671
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 7:55 PM ET
- Size
- 6.2 KB